Search

Displaying results 1751 - 1760 of 9715 in total
  1. Drug

    Ethyl cartrizoate

    go.drugbank.com/drugs/DB20328
    Experimental

    Ethyl cartrizoate is a small molecule drug. Ethyl cartrizoate has a monoisotopic molecular weight of 699.81 Da.

  2. Drug

    Triamcinolone furetonide

    go.drugbank.com/drugs/DB21010
    Experimental

    Triamcinolone furetonide is a small molecule drug. Triamcinolone furetonide has a monoisotopic molecular weight of 578.23 Da.

  3. Drug

    Sorbitan trioleate

    go.drugbank.com/drugs/DB21103
    Experimental

    Sorbitan trioleate is a small molecule drug. Sorbitan trioleate has a monoisotopic molecular weight of 956.8 Da.

  4. Drug

    Bensuldazic acid

    go.drugbank.com/drugs/DB21135
    Experimental

    Bensuldazic acid is a small molecule drug. Bensuldazic acid has a monoisotopic molecular weight of 282.05 Da.

  5. Drug

    Amfonelic acid

    go.drugbank.com/drugs/DB21147
    Experimental

    Amfonelic acid is a small molecule drug. Amfonelic acid has a monoisotopic molecular weight of 308.12 Da.

  6. Drug

    Xanoxic acid

    go.drugbank.com/drugs/DB21173
    Experimental

    Xanoxic acid is a small molecule drug. Xanoxic acid has a monoisotopic molecular weight of 298.08 Da.

  7. Drug

    Tizoprolic acid

    go.drugbank.com/drugs/DB21293
    Experimental

    Tizoprolic acid is a small molecule drug. Tizoprolic acid has a monoisotopic molecular weight of 171.04 Da.

  8. Drug

    Hydroxytoluic acid

    go.drugbank.com/drugs/DB21441
    Experimental

    Hydroxytoluic acid is a small molecule drug. Hydroxytoluic acid has a monoisotopic molecular weight of 152.05 Da.

  9. Drug

    Pregabalin naproxencarbil

    go.drugbank.com/drugs/DB21744
    Experimental

    Pregabalin naproxencarbil is a small molecule drug. Pregabalin naproxencarbil has a monoisotopic molecular weight of 459.23 Da.

  10. Drug

    Cabergoline

    go.drugbank.com/drugs/DB00248
    ApprovedInvestigational

    Cabergoline, an ergot derivative, is a long-acting dopamine agonist and prolactin inhibitor. It is used to treat hyperprolactinemic disorders and Parkinsonian Syndrome.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexProducts: CABERGOLIN-1A PHARMA1MG, CABERGOLIN-1A PHARMA2MG